Canada markets open in 25 minutes

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3831-0.0030 (-0.77%)
At close: 3:58PM EDT
Full screen
Loading interactive chart...
  • Khiron Opens First Zerenia™ Clinic in Peru, Prescribing High and Low THC Medical Cannabis Products to Patients
    CNW Group

    Khiron Opens First Zerenia™ Clinic in Peru, Prescribing High and Low THC Medical Cannabis Products to Patients

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announces the launch of its first ZereniaTM clinic outside of Colombia, in Lima, Peru. Following the success of the Company's clinic strategy in Colombia, the new clinic has been established as a strategic partnership between Khiron and Clinica Montesur, a specialized medical provider in Lima with o

  • Khiron receives its largest European medical cannabis shipment to date
    CNW Group

    Khiron receives its largest European medical cannabis shipment to date

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, is pleased to announce the receipt of the Company's largest ever shipment of EU-GMP certified medical cannabis product for distribution and sale into the German market.

  • Ramping Sales of Medical Cannabis Critical for Long-Term Growth of Khiron, Says ATB Capital
    FX Empire

    Ramping Sales of Medical Cannabis Critical for Long-Term Growth of Khiron, Says ATB Capital

    ATB Capital said in its latest report that Khiron’s strategy of vertical integration supports sales growth at attractive margins and as medical cannabis revenue increases, they expect Khiron’s sales growth and gross margin expansion to be meaningful over the long term, supporting a constructive outlook.